Science Explorer Back to mapMap
Discussion
Company · Nanjing · China

Simcere Pharmaceutical (China)

In research, Simcere Pharmaceutical (China) stands highest in Health Sciences (#9,106 of 9,902 worldwide), Medicine (#7,937 of 8,541 worldwide) and Life Sciences (#6,061 of 6,403 worldwide), 2022-now. Relative to its size it is most specialised in Oncology, Pulmonary and Respiratory Medicine and Molecular Biology (Oncology is 16.4× its share of world research).

simcere.comROR OpenAlex
World rank, 2022-now
#21,751
of 22,385 · #31,329 all time
Rank in China
#2,431
of 2,481
Research works
414
▲ 163% vs 2018-21
Citations
3.3k
8.0 per fractional work
Top-10% rate
10.7%
all institutions 10.0%
vs its own fields
0.90×
1.00× is exactly expected
Open access
36%
world 40%
International
6%
world 18%
Simcere Pharmaceutical (China)

What is Simcere Pharmaceutical (China) known for in research?

The fields where it stands highest, 2022-now, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorksAll time
Health SciencesDomain #9,106 of 9,902 11.6%115 #14607
MedicineField #7,937 of 8,541 11.5%113 #12878
Life SciencesDomain #6,061 of 6,403 9.3%70 #9049

Each strip is that field's whole ranked pool, with the notch where Simcere Pharmaceutical (China) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which of those standings moved

The same fields on both windows: where it stood over the whole record, and where it stands in 2022-now. The distance is the story, and it is the one thing the two rank columns above cannot show.

  1. Health Sciences#14,607 #9,106
  2. Medicine#12,878 #7,937
  3. Life Sciences#9,049 #6,061
all time2022-now, better2022-now, worse

A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.

Which fields of science does Simcere Pharmaceutical (China) work in?

In 2022-now, 57% of research at Simcere Pharmaceutical (China) is in Health Sciences, 37% in Life Sciences. Its largest fields are Medicine (56%), Biochemistry, Genetics and Molecular Biology (30%), Immunology and Microbiology (5%). It does 2.6× the world's share of Life Sciences.

Health Sciences: 124 fractional works · 57.0% of its workMedicine: 122 fractional works · 56.3% of its workOncology: 40 fractional works · 18.5% of its workPulmonary and Respiratory Medicine: 26 fractional works · 12.0% of its workRadiology, Nuclear Medicine and Imaging: 8 fractional works · 3.8% of its workSurgery: 8 fractional works · 3.8% of its workGenetics: 6 fractional works · 2.9% of its workPathology and Forensic Medicine: 6 fractional works · 2.9% of its workEpidemiology: 6 fractional works · 2.6% of its workNeurology: 3 fractional works · 1.3% of its workPhysiology: 2 fractional works · 0.9% of its workInfectious Diseases: 2 fractional works · 0.8% of its workEndocrinology, Diabetes and Metabolism: 2 fractional works · 0.8% of its workHepatology: 2 fractional works · 0.7% of its workHematology: 1 fractional works · 0.6% of its workGastroenterology: 1 fractional works · 0.6% of its workRheumatology: 1 fractional works · 0.5% of its workOtorhinolaryngology: 1 fractional works · 0.4% of its workComplementary and alternative medicine: 1 fractional works · 0.4% of its workReproductive Medicine: 1 fractional works · 0.3% of its workDermatology: 1 fractional works · 0.3% of its workPharmacology: 1 fractional works · 0.3% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 0.3% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 0.3% of its workObstetrics and Gynecology: 1 fractional works · 0.2% of its workSmaller subfields together: 2 fractional works · 1.1% of its workNursing: 1 fractional works · 0.3% of its workNutrition and Dietetics: 1 fractional works · 0.3% of its workHealth Professions: 1 fractional works · 0.2% of its workVeterinary: 0 fractional works · 0.2% of its workDentistry: 0 fractional works · 0.1% of its workLife Sciences: 80 fractional works · 36.7% of its workBiochemistry, Genetics and Molecular Biology: 64 fractional works · 29.5% of its workMolecular Biology: 38 fractional works · 17.3% of its workCancer Research: 18 fractional works · 8.3% of its workGenetics: 4 fractional works · 1.6% of its workBiotechnology: 2 fractional works · 1.0% of its workCell Biology: 1 fractional works · 0.7% of its workClinical Biochemistry: 1 fractional works · 0.4% of its workEndocrinology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workImmunology and Microbiology: 11 fractional works · 5.1% of its workImmunology: 10 fractional works · 4.8% of its workSmaller subfields together: 1 fractional works · 0.3% of its workPharmacology, Toxicology and Pharmaceutics: 2 fractional works · 0.8% of its workPharmacology: 1 fractional works · 0.4% of its workPharmaceutical Science: 1 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workNeuroscience: 2 fractional works · 0.8% of its workNeurology: 1 fractional works · 0.3% of its workCellular and Molecular Neuroscience: 1 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workAgricultural and Biological Sciences: 1 fractional works · 0.5% of its workFood Science: 1 fractional works · 0.3% of its workPlant Science: 0 fractional works · 0.2% of its workPhysical Sciences: 11 fractional works · 5.2% of its workEngineering: 4 fractional works · 1.8% of its workBiomedical Engineering: 2 fractional works · 1.0% of its workAerospace Engineering: 1 fractional works · 0.5% of its workSmaller subfields together: 1 fractional works · 0.3% of its workMaterials Science: 2 fractional works · 0.9% of its workMaterials Chemistry: 1 fractional works · 0.5% of its workBiomaterials: 1 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workChemistry: 2 fractional works · 0.8% of its workEnvironmental Science: 2 fractional works · 0.7% of its workEnvironmental Engineering: 1 fractional works · 0.3% of its workSmaller subfields together: 1 fractional works · 0.4% of its workComputer Science: 1 fractional works · 0.7% of its workComputational Theory and Mathematics: 1 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPhysics and Astronomy: 1 fractional works · 0.3% of its workStatistical and Nonlinear Physics: 1 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.0% of its workSocial Sciences: 2 fractional works · 1.0% of its workSocial Sciences: 1 fractional works · 0.6% of its workEducation: 1 fractional works · 0.3% of its workPolitical Science and International Relations: 1 fractional works · 0.3% of its workEconomics, Econometrics and Finance: 1 fractional works · 0.3% of its workEconomics and Econometrics: 1 fractional works · 0.3% of its workBusiness, Management and Accounting: 0 fractional works · 0.1% of its workDecision Sciences: 0 fractional works · 0.1% of its workALL ITS WORKSimcerePharmaceutical…218fractional works, 2022-now
Life Sciences37%Physical Sciences5%Health Sciences57%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 21 fields, with their numbers
    1. Medicine12256.3%
    2. Nursing10.3%
    3. Health Professions10.2%
    4. Veterinary00.2%
    5. Dentistry00.1%
    1. Biochemistry, Genetics and Molecular Biology6429.5%
    2. Immunology and Microbiology115.1%
    3. Pharmacology, Toxicology and Pharmaceutics20.8%
    4. Neuroscience20.8%
    5. Agricultural and Biological Sciences10.5%
    1. Engineering41.8%
    2. Materials Science20.9%
    3. Chemistry20.8%
    4. Environmental Science20.7%
    5. Computer Science10.7%
    6. Physics and Astronomy10.3%
    1. Social Sciences10.6%
    2. Economics, Econometrics and Finance10.3%
    3. Business, Management and Accounting00.1%
    4. Decision Sciences00.1%
    5. Psychology00.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What does Simcere Pharmaceutical (China) specialise in?

Where its research is concentrated relative to its size: Oncology takes 16.4× the share of its output that it takes of world research.

  1. OncologySubfield · 40.3 works16×
  2. Pulmonary and Respiratory MedicineSubfield · 26.2 works7.8×
  3. Molecular BiologySubfield · 37.6 works5.7×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.10× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 5.54× its world share, 64 worksBiochemistry, Geneti…Immunology and Microbiology: 5.05× its world share, 11 worksImmunology and Micro…Neuroscience: 0.49× its world share, 2 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 2.34× its world share, 2 worksPharmacology, Toxico…Chemistry: 0.49× its world share, 2 worksChemistryComputer Science: 0.09× its world share, 1 worksComputer ScienceEngineering: 0.12× its world share, 4 worksEngineeringEnvironmental Science: 0.15× its world share, 2 worksEnvironmental ScienceMaterials Science: 0.27× its world share, 2 worksMaterials SciencePhysics and Astronomy: 0.15× its world share, 1 worksPhysics and AstronomyDentistry: 0.12× its world share, 0 worksDentistryHealth Professions: 0.09× its world share, 0 worksHealth ProfessionsMedicine: 2.93× its world share, 122 worksMedicineNursing: 0.61× its world share, 1 worksNursingVeterinary: 1.41× its world share, 0 worksVeterinaryBusiness, Management and Accounting: 0.02× its world share, 0 worksBusiness, Management…Decision Sciences: 0.05× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.14× its world share, 1 worksEconomics, Econometr…Social Sciences: 0.05× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 5.5×. Every wedge is a field page.

All 20 fields, with their numbers
  1. Biochemistry, Genetics and Molecular Biology5.54×64 works
  2. Immunology and Microbiology5.05×11 works
  3. Medicine2.93×122 works
  4. Pharmacology, Toxicology and Pharmaceutics2.34×2 works
  5. Veterinary1.41×0 works
  6. Nursing0.61×1 works
  7. Neuroscience0.49×2 works
  8. Chemistry0.49×2 works
  9. Materials Science0.27×2 works
  10. Environmental Science0.15×2 works
  11. Physics and Astronomy0.15×1 works
  12. Economics, Econometrics and Finance0.14×1 works
  13. Engineering0.12×4 works
  14. Dentistry0.12×0 works
  15. Agricultural and Biological Sciences0.10×1 works
  16. Computer Science0.09×1 works
  17. Health Professions0.09×0 works
  18. Decision Sciences0.05×0 works
  19. Social Sciences0.05×1 works
  20. Business, Management and Accounting0.02×0 works

Who are the top researchers at Simcere Pharmaceutical (China)?

Ranked on the quality score, Renhong Tang, Xiaoxuan Wang and Dongsheng Chen lead among researchers whose main affiliation is Simcere Pharmaceutical (China).

  1. 1 Renhong Tang China · #831,667 worldwide 1k citations · 75 works
  2. 2 Xiaoxuan Wang China · #929,864 worldwide 1.9k citations · 143 works
  3. 3 Dongsheng Chen China · #1,019,762 worldwide 3.1k citations · 186 works
  4. 4 Minghui Ge China · #1,069,690 worldwide 544 citations · 36 works
  5. 5 Lele Zhao China · #1,136,265 worldwide 5.5k citations · 138 works
  6. 6 Wanglong Deng China · #1,217,263 worldwide 845 citations · 78 works
  7. 7 Chuang Qi China · #1,337,664 worldwide 1.3k citations · 106 works
  8. 8 Tiantian Han China · #1,527,214 worldwide 875 citations · 66 works
  9. 9 Ran Ding China · #2,082,500 worldwide 1.7k citations · 163 works
  10. 10 Liting Xue China · #2,266,284 worldwide 576 citations · 78 works
All ranked researchers at Simcere Pharmaceutical (China)

What are the most cited papers from Simcere Pharmaceutical (China)?

The most cited paper from Simcere Pharmaceutical (China) is "Selenium–GPX4 axis protects follicular helper T cells from ferroptosis" (Yin Yao et al., 2021), with 386 citations. Next come "Cancer SLC6A6-mediated taurine uptake transactivates immune checkpoint genes and induces exhaustion in CD8+ T cells" (227) and "Efficacy and safety of camrelizumab plus apatinib during the perioperative period in resectable hepatocellular carcinoma: a single-arm, open label, phase II clinical trial" (222).

Most cited papers
#PaperReleasedCitations
1 Selenium–GPX4 axis protects follicular helper T cells from ferroptosis Yin Yao et al. · Nature Immunology 19 Aug 2021 386
2 Cancer SLC6A6-mediated taurine uptake transactivates immune checkpoint genes and induces exhaustion in CD8+ T cells Tianyu Cao et al. · Cell Open access Apr 2024 227
3 Efficacy and safety of camrelizumab plus apatinib during the perioperative period in resectable hepatocellular carcinoma: a single-arm, open label, phase II clinical trial Yongxiang Xia et al. · Journal for ImmunoTherapy of Cancer Open access Apr 2022 222
4 Interaction of lncRNA MIR100HG with hnRNPA2B1 facilitates m6A-dependent stabilization of TCF7L2 mRNA and colorectal cancer progression Hao Liu et al. · Molecular Cancer Open access 12 Mar 2022 199
5 MYCN mediates TFRC-dependent ferroptosis and reveals vulnerabilities in neuroblastoma Yuxiong Lu, Qing Yang, Yubin Su et al. · Cell Death and Disease Open access 19 May 2021 188
All 61 most cited papers, with filters and sorting

Which keywords describe research at Simcere Pharmaceutical (China)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Targeted Therapy, Immunotherapy, Chemotherapy, Cancer, Tumor Microenvironment, Clinical Trials, Prognostic Factors and Genomic Instability.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Targeted Therapy25▲ 51×5 topics
  2. Immunotherapy25▲ 16×17 topics
  3. Chemotherapy24▲ 16×15 topics
  4. Cancer23▲ 7.8×34 topics
  5. Tumor Microenvironment22▲ 22×6 topics
  6. Clinical Trials15▲ 11×8 topics
  7. Prognostic Factors14▲ 15×12 topics
  8. Genomic Instability13▲ 55×3 topics
  9. Cancer Genomics11▲ 71×1 topic
  10. Mutational Signatures11▲ 71×1 topic
  11. Cancer Therapy11▲ 8.7×14 topics
  12. Immune Checkpoint Blockade10▲ 42×1 topic
  13. PD-1 and PD-L110▲ 42×1 topic
  14. Breast Cancer10▲ 18×7 topics
  15. Metastasis10▲ 13×9 topics
  16. Radiotherapy9▲ 11×8 topics
  17. Gene Expression9▲ 6.5×9 topics
  18. Biomarkers9▲ 5.8×8 topics
  19. Genomic Profiling8▲ 38×2 topics
  20. Treatment Guidelines8▲ 16×2 topics
  21. ALK Inhibitors8▲ 57×1 topic
  22. Cell Death8▲ 15×4 topics
  23. EGFR Mutations8▲ 57×1 topic
  24. Molecular Characterization8▲ 19×6 topics
  25. Precision Medicine7▲ 6.9×6 topics
  26. Cancer Immunotherapy7▲ 22×3 topics
  27. Glycosylation7▲ 30×3 topics
  28. Clinical Practice Guidelines7▲ 5.7×10 topics
  29. Tumor Regression6▲ 26×2 topics
  30. Monoclonal Antibodies6▲ 30×3 topics
  31. Transcriptional Regulation6▲ 16×6 topics
  32. Therapeutic Antibodies6▲ 38×2 topics
  33. Molecular Classification6▲ 17×4 topics
  34. Tumor Markers6▲ 31×2 topics
  35. Ferroptosis6▲ 31×1 topic
  36. Genomic Profiles6▲ 58×1 topic
  37. Lipid Peroxidation6▲ 23×1 topic
  38. Small-Cell Lung Cancer6▲ 58×1 topic
  39. Monoclonal Antibody5▲ 44×2 topics
  40. Cancer Progression5▲ 13×5 topics

Which research topics does Simcere Pharmaceutical (China) publish most on?

By volume in 2022-now: Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations and Ferroptosis and cancer prognosis.

Cancer Genomics and Diagnostics: 11 fractional worksCancer Immunotherapy and Biomarkers: 10 fractional worksLung Cancer Treatments a…8Lung Cancer Treatments and Mutations: 8 fractional worksFerroptosis and cancer p…6Ferroptosis and cancer prognosis: 6 fractional worksLung Cancer Research Studies: 6 fractional worksImmune Cell Function and Interaction: 5 fractional worksGlioma Diagnosis and Tre…5Glioma Diagnosis and Treatment: 5 fractional worksMonoclonal and Polyclona…5Monoclonal and Polyclonal Antibodies Research: 5 fractional worksCAR-T cell therapy resea…4CAR-T cell therapy research: 4 fractional worksHER2/EGFR in Cancer Rese…4HER2/EGFR in Cancer Research: 4 fractional works
Cancer ResearchOncologyPulmonary and Respiratory MedicineImmunology2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Cancer Genomics and Diagnostics Cancer Research 11 works
  2. 2 Cancer Immunotherapy and Biomarkers Oncology 10 works
  3. 3 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 8 works
  4. 4 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 6 works
  5. 5 Lung Cancer Research Studies Oncology 6 works
  6. 6 Immune Cell Function and Interaction Immunology 5 works
  7. 7 Glioma Diagnosis and Treatment Genetics 5 works
  8. 8 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 5 works
  9. 9 CAR-T cell therapy research Oncology 4 works
  10. 10 HER2/EGFR in Cancer Research Oncology 4 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available36.5%not open63.5%

World: 40% of research is openly available.

with international co-authors5.5%domestic only94.5%

World: 18% is written across borders.

How has Simcere Pharmaceutical (China)'s research output changed?

Output in 2022-2025 was 163% higher than in 2018-2021.

still counting2010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Simcere Pharmaceutical (China) as a percentage of every work published that year, 0.00056% in 2024.

still counting0.00050%0.0010%0.0015%Simcere Pharmaceutical (China)0.00063% in 202520102020

Fractional works of Simcere Pharmaceutical (China) over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year, against all institutions in the same year.

still counting5%10%15%all institutions10.0% in 2025Simcere Pharmaceutical (China)8.2% in 2025

Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 14.4% in 2024.

Other research institutions in Nanjing

All research institutions in Nanjing

Share Simcere Pharmaceutical (China)'s ranking

Simcere Pharmaceutical (China) on Science Explorer

A card with Simcere Pharmaceutical (China)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Simcere Pharmaceutical (China). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.